Thomson Reuters Corporation (NYSE:TRI)? has announced tonight that they have acquired GeneGo. GeneGo is a San Diego based company with offices in Moscow and Michigan that provides biology and disease information and analytics to pharmaceutical companies for research and development purposes. GeneGo will be integrated into Thomson Reuters’ Healthcare & Science business. GeneGo’s flagship product is called MetaBase, which is a knowledge base of all GeneGo’s products.